Lloyd Segal
Chief Executive Officer at REPARE THERAPEUTICS INC.
Net worth: 2 M $ as of 2022-11-29
Network origin in Lloyd Segal first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 22 | |
Therapure Biopharma, Inc.
 Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada.
15
| Subsidiary | Pharmaceuticals: Major | 15 |
Pembroke American Growth Fund, Inc.
 Pembroke American Growth Fund, Inc. Investment Trusts/Mutual FundsMiscellaneous Pembroke American Growth Fund, Inc. is an open-end investment fund. The company distributes earnings to unit holders as income, dividends or capital gains. It holds interest in pursing long-term growth through capital appreciation by investing in smaller U.S. companies to have above-average growth potential or to be undervalued. The company was founded on October 1, 1988 and is headquartered in Montreal, Canada.
7
| Mutual Fd-Open End | Investment Trusts/Mutual Funds | 7 |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Medical/Nursing ServicesHealth Services Aktis Oncology, Inc. is a biotechnology company located in Boston, MA. The company specializes in the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. The company's molecules are designed for high tumor penetration and long residence time, which maximizes tumor elimination while minimizing side effects of treatment. The approach enables clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes. Founded and incubated by MPM Capital, Aktis Oncology has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Matt M. Roden has been the CEO of the company since 2020.
7
| Holding Company | Medical/Nursing Services | 7 |
The Growth Fund of America
3
| Mutual Fd-Open End | Investment Trusts/Mutual Funds | 3 |
Versant Ventures Canada Ltd.
2
| Subsidiary | Investment Managers | 2 |
Persistence Capital Partners LP
1
| Private Eq Fd/Alt Invt | Investment Managers | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Lloyd Segal via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| The Income Fund of America | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member | |
| MORGAN STANLEY | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Pembroke Management Ltd.
 Pembroke Management Ltd. Investment ManagersFinance Pembroke Management Ltd. (Pembroke) is an independent Canadian investment management firm headquartered in Montreal, Quebec. The firm was founded in 1968 by Angus Taylor. Pembroke provides investment advisory services to individually managed accounts for institutional investors such as, but not limited to, corporate and public pension funds, endowments and foundations, private investment funds, as well as to mutual funds, and wealthy individuals. | Investment Managers | Chairman Chief Executive Officer Director of Finance/CFO | |
UBS Securities LLC
 UBS Securities LLC Investment ManagersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Investment Managers | Analyst-Equity Analyst-Equity | |
| International Growth & Income Fund | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
| SI-BONE, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| American Funds Fundamental Investors | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Director/Board Member | |
American Funds Developing World Growth & Income Fund
 American Funds Developing World Growth & Income Fund Investment Trusts/Mutual FundsMiscellaneous American Funds Developing World Growth & Income Fund is a open-end investment fund/unit trust. It intends to provide long-term growth of capital while providing current income. The fund was founded on July 25, 2013 and is headquartered in Irvine, CA. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Masters Business Admin | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree Doctorate Degree | |
| McGill University | College/University | Corporate Officer/Principal Graduate Degree | |
| Queen's University | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Graduate Degree | |
Gateway Casinos & Entertainment Ltd.
 Gateway Casinos & Entertainment Ltd. Casinos/GamingConsumer Services Gateway Casinos & Entertainment Ltd. engages in the operation and management of casinos. The company was founded in 1992 and is headquartered in Burnaby, Canada. | Casinos/Gaming | Director/Board Member Director/Board Member | |
| Concordia University | College/University | Undergraduate Degree Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| University of Montréal | College/University | Undergraduate Degree Undergraduate Degree | |
| Georgetown University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
Pembroke Private Wealth Management Ltd.
 Pembroke Private Wealth Management Ltd. Investment ManagersFinance Pembroke Private Wealth Management Ltd. (Pembroke) is a Canadian wealth advisory firm headquartered in Montréal, Canada. The firm was founded in 19988 and is a subsidiary of Pembroke Management Ltd. Pembroke offers a range of pooled and mutual funds, which provides exposure to Canadian, US, and international equities, as well as fixed-income securities. Their clients include individuals, families, foundations, and pension funds. | Investment Managers | Chief Executive Officer Director of Finance/CFO | |
1608557 Ontario, Inc.
 1608557 Ontario, Inc. BiotechnologyHealth Technology 1608557 Ontario, Inc. develops and manufacturers biologics, particularly blood-related based therapeutics. The company was founded in 1985 and is headquartered in Mississauga, Canada. | Biotechnology | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
| American Balanced Fund, Inc. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
The Catalyst Capital Group, Inc. (Canada)
 The Catalyst Capital Group, Inc. (Canada) Investment ManagersFinance The Catalyst Capital Group Inc (catalyst capital group) is private equity firm founded in 2002 by Jeremy Keele, Patrick McKenna, James Lee Sorenson. The firm is headquartered in Ontario, Canada. | Investment Managers | Founder Private Equity Investor | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
| Smallcap World Fund | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Director/Board Member | |
| PROTHENA CORPORATION PLC | Biotechnology | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Undergraduate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
Natural Market Restaurants Corp.
 Natural Market Restaurants Corp. RestaurantsConsumer Services Natural Market Restaurants Corp. develops microwave recycling technology. A restaurant and a market serving Mediterranean dishes to take out. Several locations. The company is headquartered in Toronto, Canada. | Restaurants | Director/Board Member Director/Board Member | |
Northern Biologics, Inc.
 Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Hospital/Nursing Management | Director/Board Member Director/Board Member | |
Blueline Bioscience
 Blueline Bioscience Investment ManagersFinance Blueline Bioscience acts as an alternative investment manager. The company is headquartered in Toronto, Canada. | Investment Managers | Director/Board Member Chief Executive Officer | |
| ONCORUS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| TURMERIC ACQUISITION CORP. | Financial Conglomerates | President Chairman | |
Bioimpact Capital LLC
 Bioimpact Capital LLC Investment ManagersFinance MPM BioImpact LLC (MPM BioImpact) is a venture capital firm a subsidiary of MPM Bioimpact Inc founded in 1996. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
Crossbow Therapeutics, Inc.
 Crossbow Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Crossbow Therapeutics, Inc. is a biotechnology company that aims to improve the lives of people with cancer by developing next-generation immunotherapies. The company is based in Cambridge, MA, and the CEO of the company is Briggs W. Morrison. The company's T-bolt™ therapies are designed to target previously unreachable cancer cell targets with high precision. Crossbow's approach is efficient and selective, allowing them to target the entire universe of cancer proteins, which expands the potential of antibody therapy to address many types of cancer. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Renagade Therapeutics, Inc.
 Renagade Therapeutics, Inc. BiotechnologyHealth Technology Renagade Therapeutics, Inc. is an American US-based company that aims to overcome the limitations of RNA medicines by applying their comprehensive deliver, code, edit, insert technologies to precisely correct disease on an unprecedented scale. The company has developed a broad portfolio of RNA delivery systems, which profoundly expand the array of addressable diseases. The company's proprietary, synergistic toolkit allows them to precisely deliver, code, edit, and insert RNA medicines to treat any disease, anywhere in the body. Renagade is built on a foundation of proprietary delivery technologies to unlock previously inaccessible cells, reprogramming cells with superior expression using the leading RNA coding platform via joint venture with Orna Therapeutics, enabling curative therapies by permanently correcting defective genes with proprietary technology, and industry-leading all-RNA system to enable exon or large gene insertions as a gene therapy 2.0 platform. Renagade is backed by MPM BioImpact and F2 Ventures, leading financial groups who have supported the development of over 50 products to market. | Biotechnology | Director/Board Member Founder | |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member |
Statistics
International
| United States | 33 |
| Canada | 15 |
| United Kingdom | 3 |
| France | 2 |
| Ireland | 2 |
Sectoral
| Consumer Services | 18 |
| Health Technology | 17 |
| Finance | 10 |
| Miscellaneous | 7 |
| Producer Manufacturing | 2 |
Operational
| Director/Board Member | 340 |
| Corporate Officer/Principal | 103 |
| Independent Dir/Board Member | 100 |
| Chairman | 50 |
| Undergraduate Degree | 38 |
Most connected contacts
| Insiders | |
|---|---|
| Todd Foley | 38 |
| John Freund | 37 |
| Linda Griego | 35 |
| Helen Kim | 33 |
| Guthrie Stewart | 31 |
| Glen Roane | 29 |
| Jerel Davis | 29 |
| David Bonita | 27 |
| Briggs Morrison | 26 |
| Katina Dorton | 22 |
| Gabriel de Alba | 20 |
| Ann Rhoads | 19 |
| Matt Roden | 18 |
| Raidy Kevin J. | 17 |
| Mary Haak-Frendscho | 17 |
- Stock Market
- Insiders
- Lloyd Segal
- Company connections
